159 results
424B3
BXRXQ
Baudax Bio, Inc.
22 Nov 23
Prospectus supplement
4:58pm
and the majority of expenses associated with the discontinuation were incurred by the end of the first quarter of 2023.
Cost of Sales
Historically, cost of sales … costs for personnel in research and development and pre-commercial regulatory functions.
The majority of our external research and development costs have
PRER14A
mxkcgn
25 Aug 23
Preliminary revised proxy
4:01pm
8-K
EX-10.1
h4sdkjpbrlbbnrzxm rc
25 Aug 23
Entry into a Material Definitive Agreement
8:03am
DEFA14A
xnu3t0 wvv
21 Aug 23
Additional proxy soliciting materials
8:05am
8-K
EX-4.2
ikynh6xb1uyf5098c
21 Aug 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
gt4qjbm4s4f1qrqbh
21 Aug 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-4.1
962u8o7w wts658zll62
21 Aug 23
Entry into a Material Definitive Agreement
8:00am
424B5
t2s6mpn bz18yv0
18 Aug 23
Prospectus supplement for primary offering
4:40pm
DEFA14A
EX-99.2
g8st6bq7i8fpkckbd0
9 Aug 23
Additional proxy soliciting materials
5:28pm
8-K/A
EX-99.2
xl4wlx6nsn3
9 Aug 23
Other Events
5:27pm
DEFA14A
ugu25i8f6fyyzvj
17 Jul 23
Additional proxy soliciting materials
7:05am
8-K
EX-99.1
7f759l ieuicwyxz
17 Jul 23
Other Events
7:00am
DEFA14A
s9v17 m4dn
5 Jul 23
Additional proxy soliciting materials
5:28pm